Repository logo
 
Publication

Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association.

2015Journal article Open access
Simple item page
dc.contributor.authorCardim, N
dc.contributor.authorGalderisi, M
dc.contributor.authorEdvardsen, T
dc.contributor.authorPlein, S
dc.contributor.authorPopescu, BA
dc.contributor.authorD'Andrea, A
dc.contributor.authorBruder O, O
dc.contributor.authorCosyns, B
dc.contributor.authorDavin, L
dc.contributor.authorDonal, E
dc.contributor.authorFreitas, A
dc.contributor.authorHabib, G, e outros
dc.date.accessioned2016-03-29T14:16:23Z
dc.date.available2016-03-29T14:16:23Z
dc.date.issued2015
dc.description.abstractTaking into account the complexity and limitations of clinical assessment in hypertrophic cardiomyopathy (HCM), imaging techniques play an essential role in the evaluation of patients with this disease. Thus, in HCM patients, imaging provides solutions for most clinical needs, from diagnosis to prognosis and risk stratification, from anatomical and functional assessment to ischaemia detection, from metabolic evaluation to monitoring of treatment modalities, from staging and clinical profiles to follow-up, and from family screening and preclinical diagnosis to differential diagnosis. Accordingly, a multimodality imaging (MMI) approach (including echocardiography, cardiac magnetic resonance, cardiac computed tomography, and cardiac nuclear imaging) is encouraged in the assessment of these patients. The choice of which technique to use should be based on a broad perspective and expert knowledge of what each technique has to offer, including its specific advantages and disadvantages. Experts in different imaging techniques should collaborate and the different methods should be seen as complementary, not as competitors. Each test must be selected in an integrated and rational way in order to provide clear answers to specific clinical questions and problems, trying to avoid redundant and duplicated information, taking into account its availability, benefits, risks, and cost.pt_PT
dc.identifier.citationEur Heart J Cardiovasc Imaging. 2015 Mar;16(3):280pt_PT
dc.identifier.issn2047-2412
dc.identifier.urihttp://hdl.handle.net/10400.10/1596
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherEuropean Association of Echocardiography; European Society of Cardiologypt_PT
dc.relation.publisherversionhttp://ehjcimaging.oxfordjournals.org/content/ejechocard/16/3/280.full.pdfpt_PT
dc.subjectHypertrophic cardiomyopathypt_PT
dc.subjectDoppler echocardiographypt_PT
dc.subjectCardiomiopatia hipertróficapt_PT
dc.subjectEcocardiografia dopplerpt_PT
dc.titleRole of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association.pt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.conferencePlaceOxfordpt_PT
oaire.citation.startPage280pt_PT
oaire.citation.titleEuropean Heart Journal Cardiovascular Imaging.pt_PT
oaire.citation.volume16pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Collections

CAR - Artigos publicados em revistas indexadas